MiR-145-5pは,SMAD5/サイクリンD1を調節することで,胃がんの進行を抑制します.
PubMedで要約を見る
まとめ
この要約は機械生成です。この研究では,miR- 145- 5pは胃がん (GC) のダウンレギュレーションにより,がん細胞の増殖と細胞周期の進行を抑制することが判明しました. miR-145-5p/SMAD5/サイクリンD1軸は,GC治療のための潜在的な予後バイオマーカーを提供します.
科学分野
- 分子腫瘍学
- 癌の生物学
- 遺伝学とゲノミクス
背景
- 胃がん (GC) は複雑で基礎的な分子メカニズムを持つ世界的な健康問題です.
- マイクロRNA (miRNA) の調節不良は,GCを含む様々な癌において重要な役割を果たします.
- 新しい分子標的を特定することは,GCの診断と治療戦略の改善に不可欠です.
研究 の 目的
- 胃がんにおけるmiR-145-5pの役割と調節メカニズムを調査する.
- miR-145-5pがGC細胞増殖と細胞サイクルに与える影響を決定する.
- GCにおけるmiR-145-5pの潜在的治療および予後値を探求する.
主な方法
- TCGAデータベースとMicroarray分析を使用して,GCで微分発現したmiRNAを特定しました.
- GC組織と細胞におけるmiR-145-5p発現を検証するために定量的リアルタイムPCR (qRT-PCR) を使用した.
- 細胞増殖アッセイ (CCK-8,Edu) とフローサイトメトリを細胞サイクル効果を評価するために実施した.
- 生物情報学と二重ルシフェラーゼレポーターアッセイを用いて,miR-145-5pのダウンストリーム標的遺伝子をスクリーニングし,検証した.
- 免疫ヒストケミストリーとウェスタン・ブロットによるタンパク質発現を調査した.
主要な成果
- miR- 145- 5pの発現は,隣接する組織と比較して,GC組織および細胞において有意に低かった.
- miR- 145- 5pの発現が低下すると,GC患者の予後が悪かった.
- miR- 145- 5pの過剰発現はGC細胞の増殖を抑制し,G1/ S相細胞サイクル停止を引き起こした.
- miR-145-5pはSMAD5を直接標的とし,増殖を抑制し,G1/S相移行を停止する.
- SMAD5の減少は細胞サイクル進行の重要なレギュラーであるサイクリンD1の発現を減少させた.
結論
- miR-145-5p/SMAD5/サイクリンD1軸は,GCにおける細胞サイクル進行と増殖の重要なレギュラーである.
- miR-145-5pは胃がんの腫瘍抑制剤として作用する.
- この軸は,有望な新しい予後バイオマーカーであり,GC治療の潜在的な治療目標です.
関連する概念動画
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Three of the best-understood negative regulators are p53, p21, and retinoblastoma protein (Rb). The regulatory roles of each of these proteins were discovered after faulty copies were found in cells with uncontrolled replication (i.e.,...
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...

